3651 results for «301»
3651 results
Complication cases - Best case submissions
06 Dec 2023 – From GulfPCR-GIM 2023
Benefit from a selection of 6 clinical cases whose complications are particularly interesting to discuss, including pericardial effusion following circumflex artery intervention, or Rota burr incarceration, to perfect your knowledge and gain tips and tricks to manage them better when you, in turn, come up against...
How should I treat my female patients?
07 Dec 2023 – From GulfPCR-GIM 2023
This 100% all-female session, in every aspect, highlights the fact that female patients have a higher prevalence of SCAD and MINOCA, focuses on the advances in everyday technologies such as intracoronary imaging and intracoronary functional assessment that facilitate the establishment of a definitive diagnosis in many...
Five most impactful trials in 2023
02 Jan 2024 – From GulfPCR-GIM 2023
Find out how, based on an initial clinical situation, the scientific evidence gathered between January and December on the key subjects selected for 2023, focusing on coronary issues, might have had an impact on daily practice, or is encouraging changes in practice, from MVD in ACS...
Cracking new horizons across all calcium morphologies
07 Dec 2023 – From GulfPCR-GIM 2023
Watch this session to learn all about the intravascular lithotripsy (IVL) mechanism for treating calcified lesions. Discover practical advice and techniques for implementing IVL in challenging calcified lesions and the safe utilization of IVL in left main bifurcations.
Ultra-low contrast techniques in complex and high-risk coronary interventions
07 Dec 2023 – From GulfPCR-GIM 2023
Explore this session to gain insights into reducing operator reliance on contrast in PCI for enhanced safety and quality, particularly in complex scenarios. Discover essential tips, tricks, and specialized tools tailored for ultra-low-contrast PCI. Additionally, immerse yourself in a practical, step-by-step example through a recorded ultra-low-contrast...
Complex PCI in high bleeding risk patients, the way forward!
07 Dec 2023 – From GulfPCR-GIM 2023
Consult this session for insights on customizing PCI strategies for high-bleeding-risk patients, and selecting Drug-Eluting Stents in complex PCI. Additionally, examine the outcomes of the Ultimaster DES in high-bleeding-risk trials, particularly in the context of short Dual Antiplatelet Therapy.
Challenging structural interventions: part 1
06 Dec 2023 – From GulfPCR-GIM 2023
In these slides, explore a selection of cases focusing on challenging structural interventions, with a case of complex bicuspid aortic valve, and a special focus on TAVI dysfunction.
OCT-guided PCI for a patient with calcified lesion
07 Dec 2023 – From GulfPCR-GIM 2023
Consult this session to gain insights into the significance of actionable intracoronary imaging in the patient treatment journey and acquire knowledge on adopting procedural strategies. Learn about the effective utilisation of orbital atherectomy for plaque modification and the impact of DES platforms in the management of...
The PASCAL IID Registry: A prospective registry for transcatheter edge-to-edge repair in prohibitive risk patients with degenerative mitral regurgitation and complex mitral valve anatomy
17 Sep 2022
Alex Sticchi provides his take on the PASCAL IID Registry and an initial comparison with the CLASP IID. The trial was presented by Jörg Hausleiter during TCT Congress 2022.
Author
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
